Furthermore, the NAMPT inhibitor and p73 activator were able to repress Detroit 562 (containing p53 R175H) and HONE-1 (containing p53 R280T) HNSCC cell proliferation in a synergistic manner [11,12]. Here, TP53 is linked to head and neck squamous cell carcinoma.